Cytosorbents (CTSO) Shares Outstanding (2010 - 2026)

Cytosorbents' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $62.7 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.33% year-over-year to $62.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.7 million (changed 0.33% YoY) and the FY2025 annual result came in at $62.8 million, up 14.54% from the prior year.
• Shares Outstanding (Entity) was $62.7 million for Q1 2026 at Cytosorbents, roughly flat from $62.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $62.8 million in Q4 2025 and bottomed at $43.5 million in Q4 2022.
• A 5-year average of $51.9 million and a median of $54.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) changed 0.0% — and 2024, when it increased 23.81%.
• Cytosorbents' Shares Outstanding (Entity) stood at $43.5 million in 2022, then gained by 2.71% to $44.7 million in 2023, then grew by 22.78% to $54.8 million in 2024, then grew by 14.54% to $62.8 million in 2025, then slipped by 0.11% to $62.7 million in 2026.
• Business Quant data shows CTSO's Shares Outstanding (Entity) at $62.7 million in Q1 2026, $62.8 million in Q4 2025, and $62.8 million in Q3 2025.